Open Access

Establishment and evaluation of a Beagle model of grade III pancreatic trauma

  • Authors:
    • Hanjing Gao
    • Qing Song
    • Faqin Lv
    • Bin Shi
    • Pengfei Wang
    • Yiru Wang
    • Yan Zhang
    • Li Yang
    • Yukun Luo
    • Xingguo Mei
    • Jie Tang
  • View Affiliations

  • Published online on: August 24, 2018     https://doi.org/10.3892/etm.2018.6656
  • Pages: 3452-3458
  • Copyright: © Gao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Pancreatic trauma (PT) is a severe abdominal injury that is often combined with multiple organ injury. It is a severe disease that is difficult to diagnose and has a high mortality rate, particularly for grade III PT. The pathogenesis, disease progress and complications have not been fully investigated due to the lack of a reliable animal model. To address this, a Beagle model of grade III PT was established in the present study using a procedure involving rupture of the main pancreatic duct. Peripancreatic effusions and the degree of pancreatic damage were examined by routine ultrasound and contrast‑enhanced ultrasound (CEUS). Also, ascites were collected for the examination of amylase and lipase levels, and whole blood samples were collected for the analysis of amylase, lipase, C‑reactive protein (CRP), interleukin (IL)‑6 and tumor necrosis factor (TNF)‑α levels in the serum. Urine samples were also collected for the examination of trypsinogen activation peptide (TAP). In addition, the pancreas was sectioned and stained with hematoxylin and eosin. In comparison with routine ultrasound, CEUS showed a large area of focal trauma, with a depth greater than half of the anteroposterior diameter of the pancreas, with a clear boundary, clear capsular rupture and trauma induced by active bleeding. The volume of ascites peaked at 48 h post‑trauma and decreased thereafter. Amylase and lipase levels in the ascites were elevated at 24 h post‑trauma and significantly decreased at 48 and 72 h post‑trauma (P<0.01). In addition, serum amylase and lipase levels increased to peak levels at 48 h post‑trauma and then decreased (P<0.05), while serum CRP, IL‑6 and TNF‑α levels peaked at 24 h post‑trauma and then decreased (P<0.05). Urinary TAP levels also peaked at 24 h post‑trauma and subsequently decreased (P<0.05). At 72 h post‑trauma, the pancreatic cells were loosely distributed, with damaged acini, hyperchromatic nuclei and severe inflammatory cell invasion. These results indicated that the Beagle model of grade III PT was satisfactorily established, and that CEUS is potentially useful as an auxiliary diagnosis method for PT. This animal model may be useful for studying the pathogenesis, disease progress and complications of PT.
View Figures
View References

Related Articles

Journal Cover

October-2018
Volume 16 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Gao H, Song Q, Lv F, Shi B, Wang P, Wang Y, Zhang Y, Yang L, Luo Y, Mei X, Mei X, et al: Establishment and evaluation of a Beagle model of grade III pancreatic trauma. Exp Ther Med 16: 3452-3458, 2018
APA
Gao, H., Song, Q., Lv, F., Shi, B., Wang, P., Wang, Y. ... Tang, J. (2018). Establishment and evaluation of a Beagle model of grade III pancreatic trauma. Experimental and Therapeutic Medicine, 16, 3452-3458. https://doi.org/10.3892/etm.2018.6656
MLA
Gao, H., Song, Q., Lv, F., Shi, B., Wang, P., Wang, Y., Zhang, Y., Yang, L., Luo, Y., Mei, X., Tang, J."Establishment and evaluation of a Beagle model of grade III pancreatic trauma". Experimental and Therapeutic Medicine 16.4 (2018): 3452-3458.
Chicago
Gao, H., Song, Q., Lv, F., Shi, B., Wang, P., Wang, Y., Zhang, Y., Yang, L., Luo, Y., Mei, X., Tang, J."Establishment and evaluation of a Beagle model of grade III pancreatic trauma". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3452-3458. https://doi.org/10.3892/etm.2018.6656